Page last updated: 2024-08-26

p-methoxy-n-methylphenethylamine and Heart Disease, Ischemic

p-methoxy-n-methylphenethylamine has been researched along with Heart Disease, Ischemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Liang, R; Qian, J; Qu, Y; Song, N; Wang, Z; Xiong, W; Yang, Y; Zhou, R1
Kane, KA; Wainwright, CL; Walsh, SK1

Other Studies

2 other study(ies) available for p-methoxy-n-methylphenethylamine and Heart Disease, Ischemic

ArticleYear
Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 141

    Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Degranulation; Cell Line; Cell Proliferation; Dexmedetomidine; Hemodynamics; Ischemic Preconditioning; Male; Mast Cells; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; p-Methoxy-N-methylphenethylamine; Rats; Rats, Sprague-Dawley

2021
Mast cell degranulation--a mechanism for the anti-arrhythmic effect of endothelin-1?
    British journal of pharmacology, 2009, Volume: 157, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Electrocardiography; Endothelin-1; Heart Rate; Histamine Release; Injections, Intravenous; Male; Mast Cells; Myocardial Ischemia; p-Methoxy-N-methylphenethylamine; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation; Ventricular Premature Complexes

2009